$XLRN ACCELERON PHARMA INC Insider Trading Week 10/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC in week 10/2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | POPS RICHARD F | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | MCGUIRE TERRANCE | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Maniatis Tom | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Nader Francois | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Option Exercise | A | 27.97 | 36,400 | 1,018,108 | 36,400 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Grant | A | 0.00 | 6,000 | 0 | 84,751 | 78.8 K to 84.8 K (+7.62 %) |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | A | 27.97 | 30,800 | 861,476 | 30,800 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Grant | A | 0.00 | 5,100 | 0 | 81,223 | 76.1 K to 81.2 K (+6.70 %) |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | A | 27.97 | 36,000 | 1,006,920 | 36,000 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Grant | A | 0.00 | 6,000 | 0 | 97,604 | 91.6 K to 97.6 K (+6.55 %) |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | A | 27.97 | 45,000 | 1,258,650 | 45,000 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Grant | A | 0.00 | 7,500 | 0 | 127,156 | 119.7 K to 127.2 K (+6.27 %) |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | A | 27.97 | 30,800 | 861,476 | 30,800 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Grant | A | 0.00 | 5,100 | 0 | 92,600 | 87.5 K to 92.6 K (+5.83 %) |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | A | 27.97 | 105,000 | 2,936,850 | 105,000 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Grant | A | 0.00 | 17,500 | 0 | 136,584 | 119.1 K to 136.6 K (+14.70 %) |